Invention Grant
- Patent Title: Xanthine dehydrogenase (XDH) IRNA compositions and methods of use thereof
-
Application No.: US16752742Application Date: 2020-01-27
-
Publication No.: US11319539B2Publication Date: 2022-05-03
- Inventor: Kevin Fitzgerald , Gregory Hinkle , Timothy Ryan Mooney
- Applicant: Alnylam Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: McCarter & English, LLP
- Agent Maria Laccotripe Zacharakis; Deborah L. Nagle
- Main IPC: C12N15/113
- IPC: C12N15/113 ; A61K9/00 ; A61K31/713 ; A61K47/14
Abstract:
The present invention relates to RNAi agents, e.g., double stranded RNAi agents, targeting a xanthine dehydrogenase (XDH) gene, and methods of using such double stranded RNAi agents to inhibit expression of an XDH gene and methods of treating subjects having an XDH-associated disease.
Public/Granted literature
- US20200299698A1 XANTHINE DEHYDROGENASE (XDH) IRNA COMPOSITIONS AND METHODS OF USE THEREOF Public/Granted day:2020-09-24
Information query
IPC分类:
